Richard Markus

Richard Markus is the CEO of Dantari, Inc., a clinical-stage biotechnology company focused on developing advanced therapeutics for cancer treatment since February 2019. Prior to this role, Richard served as Vice President of Global Development at Amgen from February 2006 to February 2019 and held the position of Senior Medical Director at Corus Pharma from 2003 to 2006. Earlier experience includes serving as Medical Director at Allecure (Mannkind) from 2000 to 2003. Richard holds a Doctor of Medicine (MD) and a Doctor of Philosophy (PhD) in Epidemiology from the University of Southern California, completed in 1997, along with a Bachelor of Science (BS) in Cybernetics from UCLA, achieved in 1988.